Clinical and biological differences between cryoglobulinaemic and hypergammaglobulinaemic purpura in primary Sjögren's syndrome: Results of a large multicentre study

Scandinavian Journal of Rheumatology

Volumn 44, Issue 1, 2015, Pages 36-41

  Quartuccio, L ^a   Isola, M ^a   Baldini, C ^b   Priori, R ^c   Bartoloni, E ^d   Carubbi, F ^e   Gregoraci, G ^a   Gandolfo, S ^a   Salvin, S ^a   Luciano, N ^b   Minniti, A ^c   Alunno, A ^d   Giacomelli, R ^e   Gerli, R ^d   Valesini, G ^c   Bombardieri, S ^b   De Vita, S ^a  

^a UNIVERSITY OF UDINE   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d UNIVERSITY OF PERUGIA   (Italy)

^e UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CRYOGLOBULIN; IMMUNOGLOBULIN; LA ANTIBODY; RHEUMATOID FACTOR; RO ANTIBODY; ANTIGEN ANTIBODY COMPLEX;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CRYOGLOBULINEMIA; FEMALE; HUMAN; HYPERGAMMAGLOBULINEMIA; IMMUNOGLOBULIN BLOOD LEVEL; LARGE CELL LYMPHOMA; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PERIPHERAL NEUROPATHY; PHENOTYPE; PRIORITY JOURNAL; SJOEGREN SYNDROME; ANTIGEN ANTIBODY COMPLEX; B LYMPHOCYTE; BLOOD; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; IMMUNOLOGY; ITALY; LYMPHOMA; MIDDLE AGED; MULTIVARIATE ANALYSIS; PRECANCER; PROGNOSIS; PURPURA; RETROSPECTIVE STUDY; VASCULITIS;

ADULT; ANTIGEN-ANTIBODY COMPLEX; B-LYMPHOCYTES; CROSS-SECTIONAL STUDIES; CRYOGLOBULINEMIA; FEMALE; HUMANS; ITALY; LYMPHOMA; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PRECANCEROUS CONDITIONS; PROGNOSIS; PURPURA, HYPERGLOBULINEMIC; RETROSPECTIVE STUDIES; SJOGREN'S SYNDROME; VASCULITIS;

EID: 84920837930     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.3109/03009742.2014.923931     Document Type: Article

References (29)

1. Tzioufas AG, Katsikis PD, Youinou PY, Moutsopoulos HM. Sjögren's syndrome: an oligo-monoclonal B cell process. Clin Exp Rheumatol 1990;8(Suppl 5):17-21.
2. Tzioufas AG, Youinou P, Moutsopoulos HM. Sjögren's syndrome. In: Isenberg DA, Maddison P, Woo P, Glass D, Breedveld F, editors. Oxford textbook of rheumatology, 3rd edn. Oxford: Oxford University Press, 2004:921-33.
3. Sugai S, Shimizu S, Tachibana J, Sawada M, Yoshioka R, Hirose Y, et al. Hypergammaglobulinemic purpura in patients with Sjögren's syndrome: a report of nine cases and a review of the Japanese literature. Jpn J Med 1989;28:148-55.
4. Alexander E, Provost TT. Sjögren's syndrome. Association of cutaneous vasculitis with central nervous system disease. Arch Dermatol 1987;123:801-10.
5. Ramos-Casals M, Anaya JM, García-Carrasco M, Rosas J, Bové A, Claver G, et al. Cutaneous vasculitis in primary Sjögren's syndrome: classification and clinical significance of 52 patients. Medicine (Baltimore) 2004;83:96-106.
6. Quartuccio L, Isola M, Corazza L, Maset M, Monti G, Gabrielli A, et al. Performance of the preliminary classification criteria for cryoglobulinaemic vasculitis and clinical manifestations in hepatitis C virus-unrelated cryoglobulinaemic vasculitis. Clin Exp Rheumatol 2012;30:S48-52.
7. Voulgarelis M, Dafni UG, Isenberg DA, Moutsopoulos HM. Malignant lymphoma in primary Sjögren's syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjögren's Syndrome. Arthritis Rheum 1999;42:1765-72.
8. Baimpa E, Dahabreh IJ, Voulgarelis M, Moutsopoulos HM. Hematologic manifestations and predictors of lymphoma development in primary Sjögren syndrome: clinical and pathophysiologic aspects. Medicine (Baltimore) 2009;88:284-93.
9. Sutcliffe N, Inanc M, Speight P, Isenberg D. Predictors of lymphoma development in primary Sjögren's syndrome. Semin Arthritis Rheum 1998;28:80-7.
10. Tzioufas AG, Boumba DS, Skopouli FN, Moutsopoulos HM. Mixed monoclonal cryoglobulinemia and monoclonal rheumatoid factor cross-reactive idiotypes as predictive factors for the development of lymphoma in primary Sjögren's syndrome. Arthritis Rheum 1996;39:767-72.
11. Anaya JM, McGuff HS, Banks PM, Talal N. Clinicopathological factors relating malignant lymphoma with Sjögren's syndrome. Semin Arthritis Rheum 1996;25:337-46.
12. Block KJ, Buchanan WW, Wohl MJ, Bunim JJ. Sjögren's syndrome. A clinical, pathological and serological study of sixty-two cases. Medicine (Baltimore) 1965;44:187-231.
13. Goltz RW, Good RA. Benign hyperglobulinemic purpura: relation to Mikulicz disease, sicca syndrome and epidermolysis bullosa dystrophia. Arch Dermatol 1961;83:26-39.
14. Alexander EL, Provost TT. Cutaneous manifestations of primary Sjögren's syndrome: a reflection of vasculitis and association with anti-Ro (SS-A) antibodies. J Invest Dermatol 1983;80:386-91.
15. Kyle RA, Gleich GJ, Bayrid ED, Vaughan JH. Benign hypergammaglobulinemic purpura of Waldenström. Medicine (Baltimore) 1971;50:113-23.
16. Alexander EL. Inflammatory vascular disease in Sjögren's syndrome. In: Talal N, Moutsopoulos HM, Kassan SS, editors. Sjögren's syndrome, clinical and immunological aspects. Berlin: Springer-Verlag, 1987:102.
17. Baldini C, Pepe P, Luciano N, Ferro F, Talarico R, Grossi S, et al. A clinical prediction rule for lymphoma development in primary Sjögren's syndrome. J Rheumatol 2012;39:804-8.
18. Vitali C, Bombardieri S, Moutsopoulos HM, Coll J, Gerli R, Hatron PY, et al. Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum 1993;36:340-7.
19. De Vita S, Boiocchi M, Sorrentino D, Carbone A, Avellini C, Dolcetti R, et al. Characterization of prelymphomatous stages of B cell lymphoproliferation in Sjögren's syndrome. Arthritis Rheum 1997;40:318-31.
20. De Vita S, De Marchi G, Sacco S, Gremese E, Fabris M, Ferraccioli G. Preliminary classification of nonmalignant B cell proliferation in Sjögren's syndrome: perspectives on pathobiology and treatment based on an integrated clinico-pathologic and molecular study approach. Blood Cells Mol Dis 2001;27:757-66.
21. Brouet JC, Clauvel JP, Danon F, Klein M, Seligmann M. Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am J Med 1974;57:775-88.
22. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8.
23. Voulgarelis M, Tzioufas AG. Pathogenetic mechanisms in the initiation and perpetuation of Sjögren's syndrome. Nat Rev Rheumatol 2010;6:529-37.
24. Gasparotto D, De Vita S, De Re V, Marzotto A, De Marchi G, Scott CA, et al. Extrasalivary lymphoma development in Sjögren's syndrome: clonal evolution from parotid gland lymphoproliferation and role of local triggering. Arthritis Rheum 2003;48:3181-6.
25. Quartuccio L, Isola M, Baldini C, Priori R, Bartoloni Bocci E, Carubbi F, et al. Biomarkers of lymphoma in Sjögren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study. J Autoimmun 2014;51:75-80.
26. De Vita S, Quartuccio L, Salvin S, Corazza L, Zabotti A, Fabris M. Cryoglobulinaemia related to Sjögren's syndrome or HCV infection: differences based on the pattern of bone marrow involvement, lymphoma evolution and laboratory tests after parotidectomy. Rheumatology (Oxford) 2012;51:627-33.
27. Quartuccio L, Salvin S, Fabris M, Maset M, Pontarini E, Isola M, et al. BLyS upregulation in Sjögren's syndrome associated with lymphoproliferative disorders, higher ESSDAI score and B-cell clonal expansion in the salivary glands. Rheumatology (Oxford) 2013;52:276-81.
28. Alexander EL, Provost TT, Stevens MB, Alexander GE. Neurologic complications of primary Sjögren's syndrome. Medicine (Baltimore) 1982;61:247-57.
29. Harley JB, Alexander EL, Bias WB, Fox OF, Provost TT, Reichlin M, et al. Anti-Ro (SS-A) and anti-La (SS-B) in patients with Sjögren's syndrome. Arthritis Rheum 1986;29:196-206.